Naproxen Msr Teva

Naproxen, the active ingredient in Naproxen Msr Teva, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for gastroenteral use. It treats pain, inflammation, fever, and arthritis in adult patients. GNH USA supplies Naproxen Msr Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces pain and inflammation across several common conditions. - Pain: provides relief from mild to moderate acute pain. - Inflammation: decreases swelling associated with musculoskeletal disorders. - Fever: helps lower elevated body temperature. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: occasional light‑headedness. - Skin rash: mild erythema or pruritus. - Elevated blood pressure: modest increase in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: may present with melena or hematemesis. - Renal impairment: reduced kidney function or acute renal failure. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Cardiovascular events: increased risk of myocardial infarction or stroke. - Severe hypersensitivity: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Renal function: assess baseline creatinine in patients with kidney disease. - Gastrointestinal risk: avoid in individuals with active ulcers or a history of GI bleeding. - Cardiovascular health: use cautiously in patients with coronary artery disease or hypertension. - Concomitant NSAIDs: do not combine with other non‑selective NSAIDs or aspirin without medical supervision. - Pregnancy and lactation: avoid unless clearly indicated by a healthcare professional. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Naproxen may alter the effect of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal hemorrhage. - ACE inhibitors or ARBs: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: possible decrease in antihypertensive efficacy. - Lithium: risk of lithium toxicity due to reduced renal clearance. - Methotrexate: may raise serum methotrexate levels, enhancing toxicity.